Eyeworld Daily News

EW SHOW DAILY 8 Dr. Steinert also spoke about his gratitude for being able to be at the forefront of laser development and stressed the importance of team- work. When asked for his advice for young ophthalmologists who want to be "the next Roger Steinert," Dr. Steinert said what people need to do is pick up little pieces here and there and incorporate them into their own personality; that's where you'll be a true innovator in your own way, he said. A new session, WTF@OIS (What's the Future), was moderat- ed by Gilbert Kliman, MD, Menlo Park, California, and Stephen Slade, MD, Houston, and featured compa- nies that are doing something new in ophthalmology. The companies included Equinox (Sioux Falls, South Dakota), Presbyopia Thera- pies (Coronado, California), Stroma Medical (Laguna Beach, California), Eyenovia (Tampa, Florida), and Wicab (Middleton, Wisconsin). Their new product ideas included goggles to help those with glaucoma and to control pressure in the eye, eye drops for presbyopia, a procedure to change eye color, microdrops using inkjet technology to print drops onto the eye, and non-surgical tech- nology to help blind people form an image of the scene around them. EW Editors' note: The speakers have financial interests with the companies represented at OIS. by Ellen Stodola EyeWorld Senior Staff Writer Abbott Medical Optics (Abbott Park, Illinois), and Alcon. The panel discussion focused on femtosecond laser-assisted cataract surgery, with panelists comment- ing on their experience, barriers to adopting the femtosecond laser for cataract surgery, and why they think this technology has taken off relative to other technologies. David Chang, MD, Los Altos, California, said that a major barrier in adoption of the femtosecond laser globally correlates with the freedom within a given economic system to bill the patient for the extra cost. This can make it a hard sell without clearly superior outcomes, he said. Eric Donnenfeld, MD, Rock- ville Centre, New York, said that he has embraced femtosecond tech- nology and has been using it for 6 years. All the platforms work very well, he said. This technology is not just making great surgeons better; it's helping everyone, he said. This year, the OIS Lifetime Inno- vator Award went to Roger Steinert, MD, Irvine, California. After the presentation of the award, Dr. Stein- ert had a conversation with Stephen Lane, MD, Stillwater, Minnesota, with Dr. Lane asking him questions about his career, technology, and his advice. When asked to choose which surgical technology he would be if he could be any technology, Dr. Steinert chose the Sinskey hook. "It's the one that's in everybody's toolbox," he said. ForSight VISION5 (Menlo Park, California), Ocular Therapeutix (Bedford, Massachusetts), and Avedro (Waltham, Massachusetts). Following the company show- case, Richard Lindstrom, MD, Min- neapolis, gave a market overview, looking at the impact of diagnos- tics on the premium channel. The session included company presen- tations from TearLab (San Diego), Alcon (Fort Worth, Texas), Carl Zeiss Meditec (Jena, Germany), and Heidelberg Engineering (Heidelberg, Germany). A panel also discussed diagnostics. One thing they agreed on was that preoperative diagnostics are very important in managing premium channel IOL patients. Warren Hill, MD, Mesa, Arizo- na, said that the "elephant in the room" is always IOL power selection. There are multiple parts to consider, and if 1 part is wrong, what you get is a refractive surprise. Diagnostics are doing well currently, he said, but formulas are still an issue. Patients want to look more at multifocality, according to Vance Thompson, MD, Sioux Falls, South Dakota. He added that diagnostics have become increasingly important with exciting new technology. There was also a spotlight on the premium channel, which featured a market overview from Elizabeth Yeu, MD, Norfolk, Virgin- ia, and company presentations from AcuFocus (Irvine, California), Bausch + Lomb (Bridgewater, New Jersey), T he Ophthalmology Innova- tion Summit (OIS) at ASCRS (OIS@ASCRS) took place on Thursday, May 5, prior to the ASCRS•ASOA Sympo- sium & Congress. As in past years, the meeting offered attendees an update on the innovation cycle and financing topics in ophthalmology. There were also company presenta- tions, as well as sessions designed to highlight anterior segment topics. William Link, PhD, San Francis- co, kicked off the meeting with an update on the OIS meeting and the innovation cycle. "We have a special opportunity to get the constituents that are necessary and required for innovation altogether in one meet- ing," he said. This year's meeting marked the 12th OIS meeting and 5th OIS@ASCRS. With about 500 attendees, it's also the largest so far at ASCRS and has expanded from a half day to nearly a full day of programming. Dr. Link highlighted several principles of innovation, which include innovation focused on important big opportunities, seeking the truth, being disciplined, trying things, being willing to fail, not being paralyzed by mistakes, being skilled, being aggressive and asser- tive but not arrogant, and being professional. Innovation happens where the innovators are and where the culture allows and fosters innova- tion, Dr. Link said. "The larger an organization is, the tougher it is to keep innovating." There is still an immense unmet need, he added, and resources are focused where they are rewarded. Innovation in the ophthalmic sector is gaining momentum, Dr. Link said. This year's Ophthalmology Innovation Showcase portion of the program featured company presentations with speakers from PowerVision (Belmont, California), Refocus Group (Dallas), ReVision Optics (Lake Forest, California), Encore Vision (Fort Worth, Texas), ClarVista Medical (Aliso Viejo, Cal- ifornia), Mynosys Cellular Devices (Fremont, California), International Biomedical Devices (Austin, Texas), Cassini (i-Optics, The Hague, the Netherlands), TearScience (Morris- ville, North Carolina), Aerie Pharmaceuticals (Irvine, California), Saturday, May 7, 2016 ASCRS News Today OIS@ASCRS presents Innovator Award to Roger Steinert, MD, highlights new technology Dr. Lane speaks with Dr. Steinert about his career, technology, and advice for young ophthalmologists.

• Cover